Get started
Author

Bikramajit Singh Saroya

Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia
2015 · Zainul S. Hasanali, Bikramajit Singh Saroya, et al. · Science Translational Medicine · 51
Off-label use of cetuximab plus sorafenib and panitumumab plus regorafenib to personalize therapy for a patient with V600E BRAF-mutant metastatic colon cancer
2013 · Mhd Yaser Al-Marrawi, Bikramajit Singh Saroya, et al. · Cancer Biology & Therapy · 34
Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs
2013 · Joshua E. Allen, Bikramajit Singh Saroya, et al. · Oncotarget · 32
PDF
Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers
2013 · Monica Dandona Desai, Bikramajit Singh Saroya, et al. · Expert Opinion on Investigational Drugs · 28
A molecularly confirmed neuroendocrine tumor resulting from Lynch Syndrome.
2013 · Steven Sorscher, Bikramajit Saroya · PubMed · 9
PDF
Contradictory KRAS mutation test results in a patient with metastatic colon cancer
2013 · Nicholas E Lamparella, Bikramajit S Saroya, et al. · Cancer Biology & Therapy · 6
PDF
Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach
2016 · Elliot M. Epner, Bikramajit Singh Saroya, et al. · Experimental Hematology · 4
P27.12.b Impact of Sequencing Temozolomide to Definitive Radiotherapy in Grade-ii Glioma- a Clinical Audit
2024 · N Kumar, A Tiwari, et al. · Neuro-Oncology
PDF
Works count: 8
Citation count: 164
H-index: 6
I10-index: 4
Year
Topic
Type